Methods and compositions for treating eye disorders
US7220422B2 · kind B2 · utility
6Cited by
27References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 20, 2003 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Oct 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivitis, fungal conjunctivitis, viral conjunctivitis, uveitis, keratic precipitates, macular edema, and inflammation response after intra-ocular lens implantation. The Clostridial toxin may be produced by a Clostridial beratti, a Clostridia butyricum, a Clostridial tetani bacterium and/or a Clostridial botulinum.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.